Avita Medical (RCEL) FCF/Share TTM: History & Chart

Avita Medical Inc.(RCEL)

Medical - Devices · Valencia, CA

$12.96-0.29 (-2.18%)

Delayed quote: Oct 6, 2026, 1:05 PM EDT

About Avita Medical Inc.

AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company’s lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitiligo lesions. It also provides RECALL autologous cell harvesting device, which can treat areas of up to 1,920 cm2; RECELL autologous cell harvesting device with ease-of-use, an enhanced ease-of-use device that can treat areas of up to 1,920 cm²; and RECELL GO mini autologous cell harvesting device, a line extension of the RECELL GO system to treat smaller wounds up to 480 cm2, as well as RECELL GO autologous cell harvesting device consisting of RECELL GO processing device, which controls and manages the pressure applied to disaggregate the donor skin cells and controls the incubation time of the RECELL Enzyme to optimize cell yield and promote cell viability; and RECELL GO preparation kit, which can treat areas up to 1,920 cm2. In addition, the company sells and distributes PermeaDerm, a biosynthetic wound matrix and Cohealyx, a collagen-based dermal matrix. It serves hospitals, treatment centers, and distributors. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical, Inc. in December 2020. AVITA Medical, Inc. is headquartered in Valencia, California.

Valencia, CA

226 employees

avitamedical.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Cary G. Vance

View full financials

FCF/Share TTM

Basis: latest reported fiscal quarter (Q2 FY2026). Source: stored company filings; unavailable inputs remain N/A.

The latest quarterly fcf/share TTM is ($0.82) with QoQ Growth of +25.68%. Trailing free cash flow divided by the latest matching quarter’s diluted weighted-average shares (basic shares when diluted shares are unavailable).

Free Cash Flow|FCF Yield|Price/FCF Ratio|Cash Flow Statement

FCF/Share TTM

RCEL FCF/Share TTM

$-0.82

Four consecutive fiscal quarters of free cash flow divided by the latest matching quarter’s weighted-average shares; no daily interpolation. Q2 FY2026 (2026-06-30): $-0.82.

+19.77% over 10Y

Unavailable TTM periods

Four matching fiscal cash-flow quarters and a matching share count are required. Unsupported windows remain N/A; single-quarter per-share values are not substituted.

31 source periods with unavailable TTM values

Cash-flow period end	FCF/Share TTM
2011-12-31	N/A
2011-09-30	N/A
2011-06-30	N/A
2011-03-31	N/A
2010-12-31	N/A
2010-09-30	N/A
2010-06-30	N/A
2010-03-31	N/A
2009-12-31	N/A
2009-09-30	N/A
2009-06-30	N/A
2009-03-31	N/A
2008-12-31	N/A
2008-09-30	N/A
2008-06-30	N/A
2008-03-31	N/A
2007-12-31	N/A
2007-09-30	N/A
2007-06-30	N/A
2007-03-31	N/A
2006-12-31	N/A
2006-09-30	N/A
2006-06-30	N/A
2005-12-31	N/A
2005-09-30	N/A
2005-06-30	N/A
2005-03-31	N/A
2004-12-31	N/A

Quarterly FCF/Share TTM History

Period	FCF/Share TTM	QoQ Growth	YoY Growth
Q2 FY2026Period end 2026-06-30	($0.82)	+25.68%	+48.33%
Q1 FY2026Period end 2026-03-31	($1.11)	(2.27%)	+37.71%
Q4 FY2025Period end 2025-12-31	($1.08)	+17.23%	+51.37%
Q3 FY2025Period end 2025-09-30	($1.31)	+17.86%	+43.05%
Q2 FY2025Period end 2025-06-30	($1.59)	+10.41%	+29.44%
Q1 FY2025Period end 2025-03-31	($1.78)	+20.15%	+12.56%
Q4 FY2024Period end 2024-12-31	($2.23)	+3.08%	(43.94%)
Q3 FY2024Period end 2024-09-30	($2.30)	(1.77%)	(83.74%)
Q2 FY2024Period end 2024-06-30	($2.26)	(11.02%)	(126.25%)
Q1 FY2024Period end 2024-03-31	($2.04)	(31.45%)	(162.45%)
Q4 FY2023Period end 2023-12-31	($1.55)	(23.71%)	(97.99%)
Q3 FY2023Period end 2023-09-30	($1.25)	(25.32%)	(49.03%)
Q2 FY2023Period end 2023-06-30	($1.00)	(28.79%)	(32.95%)
Q1 FY2023Period end 2023-03-31	($0.78)	+0.84%	(0.88%)
Q4 FY2022Period end 2022-12-31	($0.78)	+6.88%	(2.28%)
Q3 FY2022Period end 2022-09-30	($0.84)	(11.79%)	(6.03%)
Q2 FY2022Period end 2022-06-30	($0.75)	+2.27%	+31.02%
Q1 FY2022Period end 2022-03-31	($0.77)	(0.53%)	+39.67%
Q4 FY2021Period end 2021-12-31	($0.76)	+3.46%	+40.12%
Q3 FY2021Period end 2021-09-30	($0.79)	+27.27%	+35.17%
Q2 FY2021Period end 2021-06-30	($1.09)	+14.53%	+0.17%
Q1 FY2021Period end 2021-03-31	($1.27)	+0.21%	(19.87%)
Q4 FY2020Period end 2020-12-31	($1.28)	(4.51%)	(38.92%)
Q3 FY2020Period end 2020-09-30	($1.22)	(11.99%)	(35.64%)
Q2 FY2020Period end 2020-06-30	($1.09)	(2.64%)	(76.41%)
Q1 FY2020Period end 2020-03-31	($1.06)	(15.64%)	(111.11%)
Q4 FY2019Period end 2019-12-31	($0.92)	(2.04%)	+10.42%
Q3 FY2019Period end 2019-09-30	($0.90)	(45.65%)	+9.07%
Q2 FY2019Period end 2019-06-30	($0.62)	(22.82%)	+31.35%
Q1 FY2019Period end 2019-03-31	($0.50)	+50.93%	+35.42%
Q4 FY2018Period end 2018-12-31	($1.03)	(3.58%)	(10.03%)
Q3 FY2018Period end 2018-09-30	($0.99)	(9.96%)	(38.24%)
Q2 FY2018Period end 2018-06-30	($0.90)	(15.53%)	(29.55%)
Q1 FY2018Period end 2018-03-31	($0.78)	+16.38%	(13.05%)
Q4 FY2017Period end 2017-12-31	($0.93)	(30.13%)	+7.65%
Q3 FY2017Period end 2017-09-30	($0.72)	(3.05%)	+30.22%
Q2 FY2017Period end 2017-06-30	($0.70)	(0.82%)	+46.75%
Q1 FY2017Period end 2017-03-31	($0.69)	+31.69%	+46.73%
Q4 FY2016Period end 2016-12-31	($1.01)	+1.67%	(17.64%)
Q3 FY2016Period end 2016-09-30	($1.03)	+21.36%	(45.77%)
Q2 FY2016Period end 2016-06-30	($1.31)	(0.84%)	(25.82%)
Q1 FY2016Period end 2016-03-31	($1.29)	(50.86%)	(32.45%)
Q4 FY2015Period end 2015-12-31	($0.86)	(21.84%)	+31.46%
Q3 FY2015Period end 2015-09-30	($0.70)	+32.12%	+55.89%
Q2 FY2015Period end 2015-06-30	($1.04)	(6.15%)	+42.34%
Q1 FY2015Period end 2015-03-31	($0.98)	+21.93%	+47.77%
Q4 FY2014Period end 2014-12-31	($1.25)	+21.59%	+39.00%
Q3 FY2014Period end 2014-09-30	($1.60)	+11.27%	+32.09%
Q2 FY2014Period end 2014-06-30	($1.80)	+3.85%	+16.95%
Q1 FY2014Period end 2014-03-31	($1.87)	+8.81%	+10.80%
Q4 FY2013Period end 2013-12-31	($2.05)	+12.70%	+19.88%
Q3 FY2013Period end 2013-09-30	($2.35)	(8.50%)	(19.56%)
Q2 FY2013Period end 2013-06-30	($2.17)	(3.27%)	(18.88%)
Q1 FY2013Period end 2013-03-31	($2.10)	+18.09%	(32.86%)
Q4 FY2012Period end 2012-12-31	($2.56)	(30.27%)	N/A
Q3 FY2012Period end 2012-09-30	($1.97)	(7.89%)	N/A
Q2 FY2012Period end 2012-06-30	($1.82)	(15.41%)	N/A
Q1 FY2012Period end 2012-03-31	($1.58)	N/A	N/A

Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.